Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19) And Influenza Virus Types A And B in California
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in California
| Provider | Medicare | Services |
|---|---|---|
| Brio Clinical Inc | $139.71 | 10.3K |
| Arbor Vita Corporation | $139.78 | 4.5K |
| Strategic Concepts Lab Llc | $139.78 | 3.6K |
| Diagnostic Laboratory Science, Inc | $139.78 | 2.2K |
| Genentox Laboratories Llc | $139.65 | 2.1K |
| Newport Labs Inc | $139.78 | 1.9K |
| Wu, Min MD | $139.78 | 1.8K |
| Second Bio Lab Clinical Laboratory | $139.78 | 1.7K |
| Phamatech Incorporated | $139.78 | 1.5K |
| West Coast Bio Lab Llc | $139.78 | 1.3K |
| Sunrise Diagnostic Laboratories,... | $139.78 | 1.1K |
| West Coast Medical Labs Inc | $139.78 | 1.0K |
| Promis Diagnostics, Inc. | $139.78 | 936 |
| Scripps Health | $139.04 | 917 |
| First Bio Lab, Llc | $139.63 | 760 |
| Unilab Corporation | $139.78 | 738 |
| Pmh Laboratory Inc | $139.78 | 733 |
| Ananda Analytical Laboratories Llc | $139.78 | 689 |
| Alta Diagnostic Laboratories, Inc | $139.78 | 637 |
| Regents Of The University Of | $139.78 | 589 |
| Scripps Clinic Medical Laboratories | $139.78 | 511 |
| Unilab Corporation | $139.78 | 503 |
| Scripps Health | $139.00 | 497 |
| Set Labs Llc | $139.78 | 317 |
| Doonan, Bryan MD | $139.55 | 283 |
California Pricing in Context
In California, CPT code 87636 (Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19) And Influenza Virus Types A And B) carries an average Medicare payment of $139.53 - 1% above the national benchmark of $138.36. 409 providers across the state submitted claims for this procedure in 2023, performing 44.9K total services. Individual payments in CA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in California is $261.66, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount, the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because California sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Laboratory procedures, the estimated commercial insurance price in California lands near $334.87, with self-pay cash prices typically around $176.60. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19) And Influenza Virus Types A And B cost in California?
The average Medicare payment for Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19) And Influenza Virus Types A And B in California is $139.53, which is 1% above the national average of $138.36. Providers in CA typically bill $261.66 for this procedure.
What does Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19) And Influenza Virus Types A And B cost with insurance in California?
With commercial insurance in California, Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19) And Influenza Virus Types A And B costs an estimated $334.87. Without insurance, the estimated cash price is $176.60. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19) And Influenza Virus Types A And B in California?
409 providers in California billed Medicare for Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19) And Influenza Virus Types A And B in 2023, performing 44.9K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19) And Influenza Virus Types A And B cheaper in California than the national average?
No - Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19) And Influenza Virus Types A And B costs 1% above the national average in California. The state average Medicare payment is $139.53 compared to $138.36 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainProcedure is rendered directly from CMS Medicare Physician & Other Practitioners data, no number is typed in by an editor. This page draws directly on CMS Medicare Physician & Other Practitioners data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.